Givosiran
ALN-AS1-003
Phase 3 small_molecule completed
Quick answer
Givosiran for Acute Hepatic Porphyria is a Phase 3 program (small_molecule) at ALNYLAM PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ALNYLAM PHARMACEUTICALS, INC.
- Indication
- Acute Hepatic Porphyria
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed